Alnylam Pharmaceuticals, Inc.

Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic …

Biotechnology

US, Cambridge [HQ]

Lobbying · US Senate · Influence

Lobbying Analysis

Lobbying · US Senate · Influence

Here you'll find all expenses made over the past 12M of Alnylam Pharmaceuticals, Inc. to fulfill lobbying activities in the United States of America.

FY	Quarter	Lobby Expense [in mil. $]	Filing	Report Time
2024	3	6	LDA-2	Oct. 21, 2024, 4:37 p.m.
2024	3	6	LDA-2	Oct. 20, 2024, 10:35 p.m.
2024	3	6	LDA-2	Oct. 15, 2024, 10:21 p.m.
2024	2	6	LDA-2	July 22, 2024, 6:19 p.m.
2024	2	6	LDA-2	July 19, 2024, 3:23 a.m.
2024	2	6	LDA-2	July 15, 2024, 4:43 p.m.
2024	1	6	LDA-2	April 23, 2024, 2:06 a.m.
2024	1	6	LDA-2	April 22, 2024, 7:32 p.m.
2024	1	6	LDA-2	April 12, 2024, 2:38 p.m.
2023	4	5	LDA-2	Jan. 19, 2024, 5:32 p.m.
2023	4	5	LDA-2	Jan. 18, 2024, 1:36 p.m.
2023	4	6	LDA-2	Jan. 16, 2024, 2:57 p.m.